Tata Consultancy Services (TCS), a leading global IT services organization has said that it has been recognized as a Leader for Life Sciences Drug Safety Services in the IDC MarketScape, "Worldwide Life Science Drug Safety Services Vendor Assessment 2017," (IDC #US42595616, June 2017), demonstrating the most mature strategies and capabilities amongst all vendors highlighted in the report.
“The report noted TCS' solid Drug Safety IT services and well-established Business Process Services (BPS) Drug Safety capabilities, and highlights TCS' extensive experience working with life science companies, strong technical focus, and investments to drive innovation in drug safety services,” the company said in a filing to the Bombay Stock Exchange.
The IDC MarketScape assessed the capabilities and market successes of eight leading IT Service providers that serve the Life Sciences sector in Drug Safety Services. They were evaluated against breadth of service offerings, diversity of resources and infrastructure-supporting services delivery, project experience in the Life Sciences Drug Safety Services market, customer service strategy and customer satisfaction, pricing model, go-to-market capabilities, and commitment to growth and innovation in the R&D Drug Safety space.
Meanwhile, shares of the company were trading at Rs 2408.90 apiece, up 0.55 per cent from the previous close at 09:30 hours on BSE.